- Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A
- IceCure Medical CEO Issues Letter to Shareholders
- Q-Sera enters exclusive agreement with Terumo Corporation for RAPClot™ rapid serum blood collection tube technology in Japan
- Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
Terumo Corp (4543:TYO) closed at 4,274.00, 12.83% above the 52 week low of 3,788.00 set on Mar 24, 2021.
3,788.00Mar 24 20215,500.00Sep 24 2021
Markit short selling activity
|Market cap||3.22tn JPY|
|EPS (TTM)||126.10 |
|Annual div (ADY)||31.00 |
|Annual div yield (ADY)||0.75%|
|Div ex-date||Sep 29 2021|
|Div pay-date||Dec 03 2021|
|Next div ex-date||Mar 30 2022|
|Next div pay-date||--|
Data delayed at least 20 minutes, as of Jan 21 2022 06:00 GMT.